The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

Clinical trial NCT04179656 · UNKNOWN

Trial details

NCT number: NCT04179656
Sponsor: Tianjin Medical University Second Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor HER2 Gene Mutation HER-2 Gene Amplification HER-2 Protein Overexpression

Start date: 2019-12-01
Primary completion: 2021-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.